SARS-CoV-2 Total Antibody Detection ELISA Kit (Targeting RBD of Spike Proteins)

Principle of the Assay

This assay employs a quantitative sandwich enzyme immunoassay technique and is uniquely suitable for rapid high-throughput detecting the levels of the SARS-CoV-2 total antibody in serum. The recombinant SARS-CoV-2 RBD fragment has been pre-coated onto a microplate. Controls or samples are pipetted into the wells, and then a horseradish peroxidase-conjugated RBD fragment (RBD-HRP) is added to the wells, producing an antigen-antibody-antigen "sandwich complex". Following incubation and wash steps, a substrate is added. A colored product is formed in proportion to the amount of SARS-CoV-2 total antibody present in the sample. The reaction is terminated by the addition of acid and absorbance is measured at 450nm. A positive control is prepared from SARS-CoV-2 RBD antibodies to assure the validity of the results.

Target Information

Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The spike protein (S) contains a receptor-binding domain (RBD), which is responsible for recognizing the cell surface receptor, angiotensin-converting enzyme-2 (ACE2). It is found that the RBD of the SARS-CoV-2 S protein strongly interacts with the human ACE2 receptor leading to endocytosis into the host cells of the deep lung and viral replication. This kit is configured and optimized to support research for SARS-CoV-2, it can be used to detect the RBD antibodies in the serum of patients with SARS-CoV-2 infection as early as possible, and serving as a tool to evaluate the immune level of other animals to the SARS-COV-2 RBD.

Materials Supplied

Storage

Performance Characteristics